Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts and depression
Di Forti, Marta
MetadataShow full item record
Jones, P., Lopez-Morinigo, J., Ajnakina, O., Wiffen, B., Morgan, K., Doody, G., Ayesa-Arriola, R., et al. (2019). Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts and depression. Schizophrenia Research, 204 80-89. https://doi.org/10.1016/j.schres.2018.09.016
ABSTRACT Background: The role of insight dimensions – illness recognition (IR), symptoms relabelling (SR), treatment compliance (TC) - in suicide risk in first-episode psychosis (FEP) remains unclear. Method: The AESOP (n=181) and GAP (n=112) FEP cohorts were followed-up over 10- and 5 years. Survival analysis modelled time to first suicidal event in relation to baseline scores on the Schedule for the Assessment of Insight, whilst adjusting for demographic, clinical, psychopathological and neuropsychological variables.
This work represents independent research which was supported by the UK Medical Research Council (grant number G0500817) and partly-funded by the UK Department of Health via the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience at Kings College London. JDLM was funded by the British Medical Association via the Margaret Temple Research Award for Schizophrenia. PBJ received funding support from the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC), East of England. RMM was supported by the Medical Research Council and Lord Leverhulme Trust. CM is funded by grants from the Medical Research Council (grant number MR/P025927/1) and EU (grant number ERC Ref: 648837 REACH). RD is funded by a Clinician Scientist Fellowship awarded by the Academy of Medical Sciences in partnership with The Health Foundation. ASD is supported by National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London.
External DOI: https://doi.org/10.1016/j.schres.2018.09.016
This record's URL: https://www.repository.cam.ac.uk/handle/1810/290963